PEDIATRICS Vol. 55 No. 1 January 1975, pp. 68-74
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McClure, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McClure, P. D.

Idiopathic Thrombocytopenic Purpura in Children: Diagnosis and Management

P. D. McClure M.D., C.M., F.R.C.P.(C)1

1 The Hospital for Sick Children, Toronto

In children, the term idiopathic thrombocytopenic purpura (ITP) has been loosely applied to at least four conditions; postviral thrombocytopenia, "true" idiopathic thrombocytopenia in which no precipitating factor or associated illness can be found, thrombocytopenia associated with other autoimmune syndromes and drug-induced immune thrombocytopenia. Patients initially thought to have "true" ITP may later develop lupus erythematosus or hemolytic anemia and hence move from one category to another.

In 1951 Harrington demonstrated an antiplatelet factor in the serum of patients with ITP. Later this factor was proven to be an antibody of the IgG class and to be present in the blood of all four types of patients. Platelets lightly coated with antibody are sequestered and removed by the reticuloendothelial system in the spleen while more heavily coated platelets may be removed in the liver.2-4 The spleen further contributes to the thrombocytopenia by producing platelet antibodies.5-7 Recently Wybran and others8-10 have shown that cell-mediated immunity to autologous platelets may also be a factor in the pathogenesis of some cases of ITP. In view of the obvious association of ITP and altered immune mechanisms some authors have suggested the term ITP be changed to immunological or immunogenic thrombocytopenic purpura.11, 12 Karpatkin, Garg and Siskind recommend that if a platelet antibody can be demonstrated in the absence of associated disease, the term autoimmune thrombocytopenic purpura (ATP) be applied.13 Since not all patients have demonstrably altered immunity and since the cause of autoantibody production is unclear, we think the term idiopathic thrombocytopenic purpura should be retained at least for those cases in which the precipitating cause (virus or drug) cannot be identified.

Submitted on January 7, 1974
Accepted on May 9, 1974




This article has been cited by other articles:


Home page
 CLIN APPL THROMB HEMOSTHome page
A. F. Oner, A. Bay, M. Kuru, A. Uner, S. Arslan, and H. Caksen
Effects of High-Dose Methylprednisolone Therapy on Coagulation Factors in Patients with Acute Immune Thrombocytopenic Purpura
Clinical and Applied Thrombosis/Hemostasis, October 1, 2005; 11(4): 489 - 492.
[Abstract] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
C. Calpin, P. Dick, A. Poon, and W. Feldman
Is Bone Marrow Aspiration Needed in Acute Childhood Idiopathic Thrombocytopenic Purpura to Rule Out Leukemia?
Arch Pediatr Adolesc Med, April 1, 1998; 152(4): 345 - 347.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
C. A. Frankel and D. J. Pastore
Idiopathic Thrombocytopenic Purpura with Intracranial Hemorrhage and Vitreous Hemorrhage
Clinical Pediatrics, December 1, 1990; 29(12): 725 - 728.
[PDF]

Home page
 CLIN PEDIATRHome page
M. F. Rizkallah, M. H. Ghandour, R. Sabbah, and M. Akhtar
Acute Thrombocytopenic Purpura and Poststreptococcal Acute Glomerulonephritis in a Child
Clinical Pediatrics, October 1, 1984; 23(10): 581 - 583.
[PDF]